Celltrion USA has expanded access toZYMFENTRA®(infliximab-dyyb),the first and only FDA-approved subcutaneous (SC) infliximab,to a significant share of the U.S. market
HANOI,Vietnam,Oct. 31,2024-- As part of Sustainability Management,MNFV- a member of Japan\'s leading dairy and nutrition companyMorinaga Milk Group- practices human rights and diversity considerations
SHENZHEN,China,Oct. 31,2024-- Following its introduction to the Chinese market in 2021,theFormnext brand has established itself as a trusted name in the country\'s additive manufacturing (AM) and indu
BEIJING,Oct. 31,2024-- Wednesday marked the 15th anniversary of theChiNext board,a Nasdaq-style board for growth enterprises in China,which opened for trading on October 30,2009. After 15 years of rap
QINGDAO,China,Oct. 31,2024-- Haier is excited to unveil a game-changing ultrabook that sets new standards in the high-performance,lightweight laptop category. Priced at an incredibly competitive $666,
CHENGDU,China,Oct. 31,2024-- The new drug application (NDA) (the "Application") based on the positive results from the pivotalphase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-
HONG KONG,Oct. 31,2024-- As the AI 2.0 era unfolds,investing in AI infrastructure has become crucial for the future growth of AI enterprises. During the Fireside Chat "AI Innovation in Action wi
YICHUN,China,Oct. 31,2024--From October 24 to 27,14 global youth representatives from 10 countries,includingBRICS member states,visited Yichun during their participation in the Global Young Leaders Di
This approval marks the second international marketing authorization forsugemalimab outside of China,following its recent approval by the European Commission.
LONDON,Oct. 31,2024-- On October 30,2024,a renowned author,poet,and TCL NXTPAPER Global Ambassador Michael Rosen captivated a full audience at London\'s Southbank Centre in an exclusive live Q&A,b